To hear about similar clinical trials, please enter your email below
Trial Title:
Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-related Risk Factors
NCT ID:
NCT06118437
Condition:
Malignant Tumor of Digestive Tract
Risk Factors
Conditions: Official terms:
Gastrointestinal Neoplasms
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Gastrointestinal tumors (esophageal cancer, gastric cancer, colorectal cancer) seriously
threaten human health, with a high incidence rate and cancer related hope mortality.
Digestive endoscopy is the main method for screening gastrointestinal tumors. Early
screening of gastrointestinal tumors can improve the detection of early cancer and
improve prognosis. The five-year survival rate of early stage tumors after comprehensive
treatment can reach 90%, while the five-year survival rate of late stage tumors is less
than 30%. Therefore, the screening of gastrointestinal tumors is very important.
Studies have shown that there are similarities in risk factors for gastrointestinal
tumors, such as age, gender, family history, smoking, alcohol consumption, etc.
Currently, established digestive malignancies are targeted at a single malignant tumor.
At present, there is a lack of understanding of the overall risk factors associated with
gastrointestinal tumors and the establishment of relevant risk prediction models.
Therefore, we conducted a prospective, multicenter cross-sectional study to explore the
independent risk factors of combined gastrointestinal tumors and establish a risk
prediction model for combined screening of gastrointestinal tumors.
Criteria for eligibility:
Study pop:
Continuous patients who underwent both gastroscopy and colonoscopy at the digestive
endoscopy center from October 2023 to May 2025
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Individuals aged 18-80 who undergo both gastroscopy and colonoscopy simultaneously
Exclusion Criteria:
- （1）Previously diagnosed with esophageal, gastric, or colorectal cancer; (2)
Suspected presence of gastrointestinal obstruction or perforation; (3) Previous
history of esophageal, gastric, or colorectal surgery; (4) Those who are not
suitable for endoscopic examination due to serious diseases or unstable
hemodynamics; (5) Individuals who are unable to obtain relevant information due to
communication barriers such as mental or neurological disorders; (6) Pregnancy or
lactation period; (7) Not willing or unable to sign the informed consent form.
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Xijing of Digestive Diseases
Address:
City:
Xi'an
Country:
China
Contact:
Last name:
Yang lin Pan, MD
Phone:
862984771536
Email:
yanglinpan@hotmail.com
Start date:
November 15, 2023
Completion date:
May 31, 2025
Lead sponsor:
Agency:
Air Force Military Medical University, China
Agency class:
Other
Source:
Air Force Military Medical University, China
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06118437
